Public Citizen issued a statement on Tuesday calling the FDA "unconscionable" for denying a petition to ban Aricept 23, an Alzheimer's drug from manufacturer Eisai. According to Sidney Wolfe, the director of Public Citizen's Health Research Group, studies have failed to show the drug to be more effective than lower-dose drugs, but the drug did cause more vomiting, which can lead to pneumonia, gastrointestinal bleeding, esophageal rupture or death. Wolfe questioned whether the agency was "protecting the public health or, in effect, colluding with the drug industry when it denied a petition to ban Aricept 23, deciding to leave the dangerous drug on the market."
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact email@example.comRegister
Group criticizes Alzheimer's drug decision
Popular articles from this firm
If you would like to learn how Lexology can drive your content marketing strategy forward, please email firstname.lastname@example.org.
Related topic hubs
Keysight Technologies Inc
"The Newsfeeds are very relevant and topical. I gauge a firm’s expertise by the insight in their articles. In this respect, Lexology provides a buffet and I make the assessment. The quality of the newsfeeds is good and I like reading different firms' contributions on the same topic, as it provides an opportunity to compare their insights."